Monday, October 8, 2012

NHLBI Clinical Trial Pilot Studies (R34)

NHLBI Clinical Trial Pilot Studies (R34)

Department of Health and Human Services


The synopsis for this grant opportunity is detailed below, following this paragraph. This synopsis contains all of the updates to this document that have been posted as of 10/02/2012 . If updates have been made to the opportunity synopsis, update information is provided below the synopsis.
If you would like to receive notifications of changes to the grant opportunity click send me change notification emails . The only thing you need to provide for this service is your email address. No other information is requested.

Any inconsistency between the original printed document and the disk or electronic document shall be resolved by giving precedence to the printed document.
Document Type:Grants Notice
Funding Opportunity Number:PAR-13-002
Opportunity Category:Discretionary
Posted Date:Oct 02, 2012
Creation Date:Oct 02, 2012
Original Closing Date for Applications:Jan 07, 2016   
Current Closing Date for Applications:Jan 07, 2016   
Archive Date:Feb 07, 2016
Funding Instrument Type:Grant 
Category of Funding Activity:Health 
Category Explanation:
Expected Number of Awards:
Estimated Total Program Funding:
Award Ceiling:$225,000
Award Floor:
CFDA Number(s):93.233  --  National Center on Sleep Disorders Research
93.837  --  Cardiovascular Diseases Research
93.838  --  Lung Diseases Research
93.839  --  Blood Diseases and Resources Research
Cost Sharing or Matching Requirement:No

Eligible Applicants

State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled "Additional Information on Eligibility" for clarification)

Additional Information on Eligibility:

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. 

Agency Name

National Institutes of Health


The National Heart, Lung, and Blood Institute (NHLBI) encourages applications proposing pilot studies to obtain data that is critical for the design of robust clinical trials. This Funding Opportunity Announcement (FOA) should be used to fill gaps in scientific knowledge necessary to develop a competitive full-scale clinical trial. Appropriate pilot studies might demonstrate feasibility of an intervention or an experimental design, estimate intervention parameters, or gather other data important for the design of a trial. Applicants who propose solely to write a protocol or manual of operations or to develop infrastructure for a clinical trial will not be considered appropriate for to this announcement. Applications must demonstrate that the proposed pilot studies are both necessary and sufficient to permit the design of the clinical trial. During the evaluation of applications submitted to this FOA, the review group will also consider the significance and potential public health impact of the full-scale clinical trial that would be proposed following the R34 award period. The NHLBI anticipates that the R34 award period will yield robust investigator-initiated clinical trial grant applications for the evaluation of interventions for the treatment or prevention of heart, lung, blood, or sleep disorders. 

Link to Additional Information

If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

Synopsis Modification History

There are currently no modifications for this opportunity.

No comments:

Post a Comment